Combination of presepsin, soluble CD14 subtype, and B-type natriuretic peptide predicts six-month mortality in patients hospitalized for worsening heart failure
28 August 2018 (09:24 - 09:33)
Organised by:
About the speaker
Fujita Health University Second Hospital, Nagoya (Japan)
8 More presentations in this session
Doctor T. Kuragaichi (Amagasaki, JP)
Doctor T. Padro (Barcelona, ES)
Access the full session
The Event
ESC Congress 2018
28 August 2018
09:24 CET
You may be interested in
Congress Presentation
Congress Session
